Search Results 81-90 of 16853 for CLL

  1. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  2. Shanafelt Archives - Mayo Clinic News Network

    ... CLL Patients. ASCO Abstract Number: 6522 An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) ...

  3. Mayo Clinic Biobank - Cancer

    Chronic lymphocytic leukemia. Asish K. Ghosh, Ph.D., is researching the relationship of microvesicles to chronic lymphocytic leukemia (CLL) development.

  4. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  5. A Study to Evaluate the Effectiveness and Safety of Panzyga in Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (CLL) patients with secondary immunodeficiency (SID) undergoing CLL antineoplastic therapy. Participation eligibility.

  6. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    The primary purpose of this study is to evaluate the safety and tolderability of KTE-X19 in adults with relapsed/refractory chronic lymphocytic leukemia (r/r ...

  7. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia (IWCLL) criteria and having received at least 2 prior treatment regimens; CLL that warrants treatment; Clinically quantifiable ...

  8. Financial Difficulty in Patients With Blood Cancer - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250), a physician survey (n=100), and a practice survey completed by each site ...

  9. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Diagnosis of CLL according to the National Cancer Institute (NCI)/Internal Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria or small lymphocytic ...

  10. Pirtobrutinib (oral route) - Side effects & dosage - Mayo Clinic

    For mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL):. Adults—200 milligrams (mg) once a day. Your doctor may ...